Evidence map›Paper›PMID 36771383›Full record

ArticleNutrients2023

A Single Strain of

Yuying Wang, Xiaozhong Wang, Xinzhu Xiao, Shufang Yu, Wennan Huang, Benqiang Rao, Fenglin Chen

Abstract read
In one paragraph

Article in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Targeting metabolic pathways: a novel therapeutic direction for type 2 diabetes.Frontiers in cellular and infection microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuying WangDepartment of Gastrointestinal Surgery, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing 100038, China.
Xiaozhong WangDepartment of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou 350001, China.
Xinzhu XiaoDepartment of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou 350001, China.
Shufang YuDepartment of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou 350001, China.
Wennan HuangDepartment of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou 350001, China.
Benqiang RaoDepartment of Gastrointestinal Surgery, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing 100038, China.
Fenglin ChenDepartment of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou 350001, China.

Funding

National Natural Science Foundation of China 82074061
6 · The paper itself

Abstract

Type 2 diabetes (T2D) is usually accompanied by obesity and nonalcoholic fatty-liver-related insulin resistance. The link between T2D and dysbiosis has been receiving increasing attention. Probiotics can improve insulin sensitivity by regulating imbalances in microbiota, but efficacy varies based on the probiotic used. This study screened the main strain in the feces of healthy adult mice and found it to be a new

Indexed as

Diabetes Mellitus, Type 2Gastrointestinal MicrobiomeProbioticsAnimalsBifidobacteriumCholesterol, LDLDysbiosisGlucoseLactobacillusLipidsMiceCholesterol, LDLGlucoseLipidsanti-inflammatoryglucose metabolismLactobacilluslipid metabolismmicrobial transplantationtype 2 diabetes

Identifiers

PMID36771383
PMCPMC9920280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.